QScreen AI Inc. News Releases

QScreen AI Launches European Investor Roadshow Following Recent Strategic and Technology Milestones

Mon, 01 Jun 2026 07:03:00 -0400

Toronto, Ontario--(Newsfile Corp. - June 1, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announced that members of its senior leadership team will participate in a five-city investor roadshow across Central Europe from June 1 to June 5, 2026.DateCity June 1Munich, Germany June 2Ljubljana, Slovenia June 3Budapest, Hungary June 4Bratislava, Slovakia June 5Vienna, Austria Advancing Platform...

QScreen AI Appoints Former Pentagon Joint Artificial Intelligence Center Director Lt. Gen. Michael S. Groen (Ret.) to Advisory Board Following Live Platform Demonstration

Tue, 19 May 2026 07:03:00 -0400

Former US Department of Defense AI leader joins QScreen AI after reviewing the platform in person to support institutional commercialization efforts across North America Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announces the appointment of Lieutenant General Michael S. Groen (Ret.) to its Advisory Board. Lt. Gen. Groen is the former Director of the Joint...

QScreen AI Integrates Passive Voice Analysis into Multi-Signal Screening Platform - System Now Reads Physiological, Acoustic, and Behavioral Signals Simultaneously in Real Time

Wed, 06 May 2026 07:03:00 -0400

Individual voice baseline established on first encounter, deviation measured on every return visit; no additional hardware required; platform now fully integrated across all three signal modalities Toronto, Ontario--(Newsfile Corp. - May 6, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen"), today announced the full integration of a novel voice analysis engine into its multi-signal screening platform, expanding the system from camera and structured clinical intake into...

QScreen AI Reports Internal Validation Results for Correctional Intake Platform: 100% Sensitivity on Suicide Risk and Withdrawal Detection Across 65 Calibrated Clinical Scenarios

Mon, 04 May 2026 07:03:00 -0400

Nine instruments validated against published standards including Columbia C-SSRS, CIWA-Ar, and COWS; paper-only workflow showed materially lower detection rates across the same scenarios; 60-day live pilot structured and ready Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening today reports internal validation results for its correctional intake platform across 65...

QScreen AI Appoints Former Union Pacific Vice President as Strategic Advisor to Drive Expansion into North American Rail and Transportation Markets

Wed, 29 Apr 2026 07:03:00 -0400

Veteran rail executive with 25 years of senior commercial relationships across North America's Class I railroads joins a platform that enables real-time identification of probable drug use from a camera without requiring blood, breath, or urine testing.Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening, today announces the appointment of José Humberto "Beto"...

QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone - Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths

Mon, 27 Apr 2026 06:53:00 -0400

Patent-protected QAI Platform identifies the probable drug class - alcohol, opioids, benzodiazepines, stimulants, or cannabis from physiological camera data and simultaneously administers CIWA-Ar, COWS, C-SSRS and 10 further validated clinical instruments in under seven minutes with no hardware and no IT project; former Director of Pentagon Joint Artificial Intelligence Center advancing commercial engagement across US correctional facilities and national defense installations; Canadian...

QScreen AI Announces Strategic Financing to Advance Commercialization Initiatives Across North America

Thu, 26 Feb 2026 17:30:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 26, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee wellness, is pleased to announce a non-brokered private placement. The Company intends to issue (the "Offering") of up to 10,000,000 units (each, a "Unit") at a price of C$0.05 per Unit, for aggregate gross proceeds to the Company of up to C$500,000.Each Unit will be comprised of one common share of...

QScreen AI Advances Structured Commercial Discussions Following Canadian Trade Mission to Mexico

Mon, 23 Feb 2026 07:00:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 23, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee wellness, today provided an update on its participation in the official Government of Canada Trade Mission to Mexico, reporting substantive commercialization discussions with senior institutional and enterprise stakeholders as part of its broader North American growth strategy.Building on its recent...

QScreen AI Advances Quantum-Inspired Optimization with U.S. Patent Filing; Gains National Spotlight on CBC

Tue, 17 Feb 2026 07:00:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 17, 2026) - QScreen AI Inc (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening and employee wellness, today announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO). Entitled "System, Method, and Robotic Platform for Quantum-Inspired Multi-Objective Optimization of Human-Governed Clinical Intake and Readiness Data Collection Under...

Qscreen AI Announces Strategic U.S. Engagement to Drive Innovation in Public Safety and Institutional Health

Mon, 09 Feb 2026 07:01:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 9, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), a pioneering leader in artificial intelligence enabled health and safety technology, is pleased to announce that it has entered into an independent contractor agreement with Global Frontier Advisors L.P. ("GFA"), effective January 30, 2026. GFA will receive a combination of equity-based along with performance-based compensation during the term of the agreement, subject to applicable...